Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations

Authors

Abdul Aleem MD, Lehigh Valley Health NetworkFollow
Amy Slenker MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2022

Published In/Presented At

Aleem, A., & Slenker, A. K. (2022). Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations. In StatPearls. StatPearls Publishing.

Disciplines

Medicine and Health Sciences

PubMedID

34033365

Department(s)

Department of Medicine

Document Type

Book Chapter